Information Provided By:
Fly News Breaks for April 12, 2017
GMED
Apr 12, 2017 | 06:41 EDT
Leerink analyst Richard Newitter upgraded Globus Medical to Outperform and raised his price target for the shares to $40 from $29. The company's growth is "on the cusp" of an inflection, Newitter tells investors in a research note.
News For GMED From the Last 2 Days
There are no results for your query GMED